DK262585A - Polypeptider og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser - Google Patents

Polypeptider og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser Download PDF

Info

Publication number
DK262585A
DK262585A DK262585A DK262585A DK262585A DK 262585 A DK262585 A DK 262585A DK 262585 A DK262585 A DK 262585A DK 262585 A DK262585 A DK 262585A DK 262585 A DK262585 A DK 262585A
Authority
DK
Denmark
Prior art keywords
compounds
salts
polypeptides
procedures
preparation
Prior art date
Application number
DK262585A
Other languages
Danish (da)
English (en)
Other versions
DK262585D0 (da
Inventor
Bruce Hill Frank
Allen Howard Pekar
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK262585D0 publication Critical patent/DK262585D0/da
Publication of DK262585A publication Critical patent/DK262585A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK262585A 1984-06-14 1985-06-12 Polypeptider og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser DK262585A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/620,781 US4581165A (en) 1984-06-14 1984-06-14 Anti-diabetic compounds

Publications (2)

Publication Number Publication Date
DK262585D0 DK262585D0 (da) 1985-06-12
DK262585A true DK262585A (da) 1985-12-15

Family

ID=24487362

Family Applications (1)

Application Number Title Priority Date Filing Date
DK262585A DK262585A (da) 1984-06-14 1985-06-12 Polypeptider og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser

Country Status (7)

Country Link
US (1) US4581165A (de)
EP (1) EP0171887B1 (de)
JP (1) JPS6110599A (de)
AT (1) ATE86668T1 (de)
CA (1) CA1244365A (de)
DE (1) DE3587164T2 (de)
DK (1) DK262585A (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888414A (en) * 1987-04-09 1989-12-19 Board Of Regents, University Of Texas System Insulin-binding peptides and uses thereof
US4992418A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin
US4992417A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogues
US5208217A (en) * 1989-04-20 1993-05-04 Mount Sinai School Of Medicine Of The City University Of New York Hepatospecific insulin analogues
JPH05252941A (ja) * 1991-08-12 1993-10-05 Sakai Enetsukusu Kk 動物細胞培養用担体
CZ342492A3 (en) * 1991-11-26 1993-06-16 Lilly Co Eli Derivatives of tri-arginine insulin, process of their preparation and a pharmaceutical composition in which said derivatives are comprised
SE520392C2 (sv) 1996-09-27 2003-07-01 Creative Peptides Sweden Ab C Specifika peptider för behandling av diabetes mellitus
US6775451B1 (en) 1999-12-30 2004-08-10 Corning Incorporated Secondary coating composition for optical fibers
EP1250386A1 (de) 1999-12-30 2002-10-23 Corning Incorporated Klebemittelenthaltende zusammensetzung und verfahren zur veränderung von zeitempfindlichen rheologischen eigenschaften einer optischen faserbeschichtung
AU1582701A (en) 1999-12-30 2001-07-16 Corning Incorporated Optical fibers prepared with a primary coating composition including a monomer with a pendant hydroxyl functional group
KR20020067056A (ko) 1999-12-30 2002-08-21 코닝 인코포레이티드 1차 광섬유 코팅의 급속 경화방법
CA2395531A1 (en) 1999-12-30 2001-07-12 Corning Incorporated Secondary coating composition for optical fibers
EP1265630B1 (de) 2000-03-24 2006-06-07 Genentech, Inc. Verwendung von insulin zur behandlung von knorpelkrankheiten
US6584263B2 (en) 2000-07-26 2003-06-24 Corning Incorporated Optical fiber coating compositions and coated optical fibers
US6553169B2 (en) 2000-11-29 2003-04-22 Corning Incorporated Optical fiber coating compositions and coated optical fibers
US6602601B2 (en) 2000-12-22 2003-08-05 Corning Incorporated Optical fiber coating compositions
US20030077059A1 (en) * 2001-03-13 2003-04-24 Ching-Kee Chien Optical fiber coating compositions
US6628875B2 (en) 2001-07-20 2003-09-30 Corning Incorporated Optical fibers possessing a primary coating with a higher degree of cure and methods of making
US7050688B2 (en) * 2003-07-18 2006-05-23 Corning Cable Systems Llc Fiber optic articles, assemblies, and cables having optical waveguides
US7715675B2 (en) * 2003-07-18 2010-05-11 Corning Incorporated Optical fiber coating system and coated optical fiber
US9678247B2 (en) 2012-05-08 2017-06-13 Corning Incorporated Primary optical fiber coating composition containing non-radiation curable component
US9488774B2 (en) 2014-04-01 2016-11-08 Corning Incorporated Primary optical fiber coating composition containing non-radiation curable component
US9708491B2 (en) 2014-06-04 2017-07-18 Corning Incorporated Optical fiber coating and composition
US9891379B2 (en) 2014-11-14 2018-02-13 Corning Incorporated Optical fiber coating compositions with acrylic polymers
US20160177092A1 (en) 2014-12-18 2016-06-23 Corning Incorporated Optical fiber coating composition with non-reactive reinforcing agent
US10640654B2 (en) 2015-12-07 2020-05-05 Corning Incorporated Optical fiber coating and composition with UV-absorbing additive

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3209184A1 (de) * 1982-03-13 1983-09-15 Hoechst Ag, 6230 Frankfurt Verfahren zur umwandlung von praeproinsulinanaloga zu insulinen

Also Published As

Publication number Publication date
DK262585D0 (da) 1985-06-12
DE3587164T2 (de) 1993-07-15
EP0171887B1 (de) 1993-03-10
EP0171887A3 (en) 1989-01-25
DE3587164D1 (de) 1993-04-15
CA1244365A (en) 1988-11-08
JPS6110599A (ja) 1986-01-18
US4581165A (en) 1986-04-08
ATE86668T1 (de) 1993-03-15
EP0171887A2 (de) 1986-02-19

Similar Documents

Publication Publication Date Title
DK262585D0 (da) Polypeptider og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser
DK262485D0 (da) Polypeptider og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser
DK397387D0 (da) Carbostyrilderivater og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser
IT8467225A1 (it) Composti di solfonio, procedimento di preparazione di detti composti e composizioni farmacologiche contenenti i composti stessi.
DK130683A (da) Derivater af bicycliske aminosyrer, fremgangsmaader til fremstilling deraf, midler indeholdende disse forbindelser og deres anvendelse samt bicycliske aminosyrer som mellemprodukter og fremgangsmaade til fremstilling heraf
DK185685A (da) 1,4-dihydro-4-oxonaphthyridinderivater og salte deraf, fremgangsmaade til fremstilling heraf og antibakterielle midler indeholdende saadanne forbindelser
DK167187D0 (da) Carbostyrilderivater og salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse
ES552585A0 (es) Procedimiento para la union quimica de compuestos de moldeo.
DK584384D0 (da) Kemisk fremgangsmaade til fremstilling af antibiotika l 17392 (deglukoteicoplanin) eller salte deraf
DK262685D0 (da) Polypeptider og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser
DK160763C (da) Imidazooe1,5-aaapyridiner og salte deraf samt deres 5,6,7,8-tetrahydroderivater, farmaceutiske praeparater indeholdende disse forbindelser samt anvendelse af forbindelserne
DK162390C (da) Makrocycliske forbindelser, fermenteringsfremgangsmaade til fremstilling heraf, mikroorganisme til brug ved fremgangsmaaden, farmaceutiske praeparater indeholdende forbindelserne, samt anvendelse af forbindelserne til fremstilling af farmaceutiske praeparater og plantebeskyttelsesmidler
ES555804A0 (es) Procedimiento para preparar sialosilcerebrosido gm4
ES524439A0 (es) Procedimiento de obtencion de los 2-amino 5- (aralcoil piperidino alcoil) amino 1,4-diazoles
DK46086D0 (da) Prinycinkomponenter eller salte deraf, fremgangsmaade til deres fremstilling samt deres anvendelse som antibiotika
DK319384A (da) 1-0-alkyl-3-amino-propan-1,2-diol-2-0-phospholipider, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende disse
DK192890D0 (da) 24r-scumnol, fremgangsmaade til fremstilling heraf samt anvendelse af samme
ES507180A0 (es) Procedimiento de preparacion de amino alcosi furanos o tio- fenos.
DK66980A (da) Fremgangsmaade til fremstilling af azacyclyl (thio) ureidoacetamidocphem-forbindelser og salte deraf samt anvendelse deraf
NO863785L (no) Sporlegger for langrennsloeyper.
IT8521460A0 (it) Procedimento di preparazione di derivati eterociclici.
IT8419896A0 (it) Procedimento per il condizionamento e la disidratazione di fanghi primari contenenti solfuri.
DK222886A (da) Propionylanilider, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende disse forbindelser
DK551183D0 (da) Substituerede 9h-8-oxo-pyrimido(2,1-f)purin-2,4-dioner, fremgangsmade til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
IT8521741A0 (it) Procedimento di fresatura chimica automatizzato.

Legal Events

Date Code Title Description
ATS Application withdrawn